Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | +6.90% | +4.10% | +43.81% |
May. 06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
May. 06 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2K | Sales 2025 * | 5M | Capitalization | 709M |
---|---|---|---|---|---|
Net income 2024 * | -222M | Net income 2025 * | -253M | EV / Sales 2024 * | 293,805 x |
Net cash position 2024 * | 121M | Net cash position 2025 * | 471M | EV / Sales 2025 * | 47.6 x |
P/E ratio 2024 * |
-3.21
x | P/E ratio 2025 * |
-3.07
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.33% |
1 day | +6.90% | ||
1 week | +4.10% | ||
Current month | +28.57% | ||
1 month | +15.77% | ||
3 months | +50.00% | ||
6 months | +49.20% | ||
Current year | +43.81% |
Managers | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Charles Newton
DFI | Director of Finance/CFO | 53 | 21-01-31 |
Stephen Hill
COO | Chief Operating Officer | 53 | 19-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
CEO | Chief Executive Officer | 65 | 21-04-30 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-08-31 |
Otis Brawley
BRD | Director/Board Member | 64 | 21-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +9.08% | - | |
0.01% | 234 M€ | +6.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.78 | +6.51% | 648,057 |
24-05-15 | 2.61 | +2.76% | 493,041 |
24-05-14 | 2.54 | +5.83% | 435,038 |
24-05-13 | 2.4 | -2.44% | 591,478 |
24-05-10 | 2.46 | -8.21% | 651,252 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.81% | 709M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.44% | 22.28B | |
-11.90% | 22.41B | |
-5.24% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- LYEL Stock